W A L E S M E D I C A S P E C I A L 2 0 0 9

MEDIWALES IS SUPPORTED BY THE WELSH ASSEMBLY GOVERNMENT

W A L E S m e d i c a s p e c i a l

This MediWales ‘Medica Special’Review is your introduction to thethriving medical technology sector inWales. It includes a directory of all ofthose companies on the InternationalBusiness Wales Medica mission 2009,as well as a snapshot of some of themost exciting products and servicesbeing offered by Welsh companies inthis sector.

Medica is the largest and leadingglobal exhibition for the medical sector.It runs alongside the leadinginternational fair for medicalmanufacturing supplies, Compamed.Medica and Compamed together willoccupy all 18 halls of the DüsseldorfExhibition Centre and organisers expectmore than 137,000 visitors from over100 countries.

Medica covers the entire range of out-patient and in-patient healthcare,including: electrical medicine/medicaldevices, laboratorytechnology/diagnostics, physiotherapy,orthopaedic technology, medicalsupplies (essential supplies andconsumables), information andcommunication technology, textiles,medical furniture, furnishings, facilitymanagement, building services.

At the same time, Compamedaddresses all aspect of supplies to themedical manufacturing sector: rawmaterials, components, parts,packaging, services for use in medicaldevice production.

International Business Wales (IBW) isthe Welsh Assembly Government’sinternational trade and investmentarm, forming part of the Department ofInnovation, Enterprise and Networks. Itacts as the driving force in establishing

alliances between companies in Walesand their counterparts overseas. At thesame time IBW actively seeks outinward investment opportunities forclient companies looking to Europeand the UK as a preferred internationalbusiness location.

The Welsh Assembly Government is ademocratically elected body, which wasestablished in May 1999. It hasdevolved powers and responsibilitiesfor developing and implementingpolicies in Wales on a broad range ofissues, including economicdevelopment, education, theenvironment, agriculture, housing,roads and transport. The WelshAssembly Government works closelywith primary legislation and haspowers to introduce secondarylegislation of its own.

MediWales has been active for overseventeen years and is therepresentative body for the medicalsector in Wales. Supported by theWelsh Assembly Government,MediWales is owned by its membersand led by directors drawn from seniorindustrialists and academics in Wales.MediWales generates a uniqueenvironment for networking,collaboration and communicationbetween industry, higher educationand health service members. This isdelivered through an active schedule ofseminar events and publications,supported by the MediWales websiteand maintained via constantcommunication with members andstakeholders. From this pivotal role,MediWales is able to represent both itsmembers and the wider sector togovernmental and internationalpartners.

MediWales is a founder member of Medilink UK, the network of regionalmedical technology organisations that represents the interests of around3000 organisations across the UK.

Medica 18-21 November 2009 - Messe Düsseldorf, Germany

The Welsh Pavilion: Hall 16 Stand F30Contents

Paths out of recession 4

Wales Pavilion Directory 9-17

Boots Centre for Innovation 19

DTR 20

GX Group 21

PDR 22

7 Schooner Way, Atlantic Wharf, Cardiff CF10 4DZTelephone: +44 (0)29 2047 3456Forum Manager: gwyn.tudor@mediwales.comProject Manager: debbie.laubach@mediwales.comProject Coordinator: jess.fisher@mediwales.com(Contact for editorial and advertising)

Web: www.mediwales.com

MediWales Chairman: Mr Greg Baily, Huntleigh

The MediWales Medica Special is designed byTeamworks Design Consultants

M E M B E R

Last year’s Review of the Welsh Bioscience

sector highlighted an era of mergers and

acquisitions for Indigenous Welsh

Companies. A year later – and over a year

into the global recession – the Review tells a

different narrative, one that illustrates the

growth in significance for Welsh Bioscience

and Medical Technology companies as they

attempt to keep the credit-crunch at bay.

In March of this year, the Welsh AssemblyGovernment commissioned MediWales – Wales’sMedical Technology and Bioscience forum – to‘map’ the Welsh Bioscience sector. This projectresulted in key findings: there are 322 companiesin Wales defined as ‘Bioscience’; the sectoremploys more than 15,000 people; andcontributes more than £1.3 billion to the Welsheconomy. Key opinion leaders knew Bioscience inWales was strong, but these figures substantiateits value, emphasising the sector’s worth as afield for future investment.

The sector’s segmentation by activity provides further insight intoWales’s strengths, but also highlights how international trade showslike Medica are vital to the growth and success of the sector. 63% ofcompanies operating under the umbrella of Bioscience are MedicalTechnology companies. With this many businesses producinginnovative medical devices, in a sector characterised by its globalmarkets, the potential for international trade is huge. Alreadystatistics for the first quarter of 2009 showed that Welsh healthcareexports grew by 9.3%, seeing a rise from £187m to £205m. Theseindicators suggest that Welsh Medical Technology companies aremore than able to trade themselves out of the recession.

Adding to this argument, when MediWales Members were askedwhat their priorities were in this difficult economic climate,surprisingly, they were not funding or investment capital. Thoughobviously significant, most of our companies said that if MediWalescan create opportunities for its members to do business, thensustainability and growth would follow.

MediWales has collected evidence indicating that access to clinicalexpertise and facilities for product evaluations and trials is a criticalsuccess factor for its membership. In a survey of the currentsituation, MediWales requested case studies of companies’successes in procurement and/or any problems experienced. Theresounding reply was that the most significant issue facing ourcompanies is access to clinical expertise throughout the productdevelopment process and if this could be improved, then companiescould resist difficult financial times.

These messages led to the MediWales ‘Clinical Access’ initiative: aworking group that has brought together key players and opinionleaders from academia, business and clinical institutions acrossWales in order to discuss and implement necessary change. This

W A L E S m e d i c a s p e c i a l4 5

vibrant interdisciplinary initiative,supported and observed by the WelshAssembly Government, has beendiscussing the following areas: earlystage evaluation of ideas; needsassessment; evidence gathering (notalways formal clinical trials); productassessment by the UK National HealthService; and procurement. The groupis working hard to improve access inall of these areas. Early talks haveresulted in progress on establishingthe evidence required by procurementand some Welsh companies havesucceeded in getting products closerto market, such as DTR Medical,Convatec, and Invacare. Other outputsinclude the proposed development of a

to create successful clinical pathwaysand systems of its own if it takesadvantage of the benefits size anddevolution brings.

A re-occurring annual Welsh highlightis the BioWales conference, tradeshowand brokerage event – one of the UK’slargest Bioscience conferences andbio-partnering events. Now in itseighth year, BioWales has become alandmark event, attracting delegatesfrom throughout the UK and Europe.The success of Bioscience relies onsuccessful connections andcollaborations between its institutions.BioWales promotes and provides aplatform for vital networking yearafter year, offering continuity and theright environment - a major factor inits popularity. Next year theconference takes place between 17-18March, at the Vale Hotel near Cardiff.

The bio-partnering event specificallyencourages internationalcollaborations between the UK andEurope through its one-to-onemeetings. The people interested inbrokerage meetings are linked up bythe Enterprise Europe Network (EEN),which brings together those seekingand those offering technologyopportunities as well as supportingaccess to European-wide researchfunding frameworks. The activity fromBioWales feeds into EEN activities thatthe Welsh Assembly Government’sDepartment for Economy andTransport facilitates throughout theyear, which often leads to

cell industrialisation; point-of-carediagnostics; cancer genetics; andtranslational research, reflecting thecurrent academic and industrialexcellence in both Wales and UK-wide.

Paths out of recession by Jess Fisher

£1.3 billion tothe Welsheconomy

322 Biosciencecompanies

15,000employees

‘clinical access route map’: this will notonly layout clear pathways forhealthcare companies to follow acrossthe five identified stages, but it willdetail who to communicate with inWales and how to proceed.

The fact that this working group wasable to materialise at all highlightsanother of Wales’s strengths. Keyopinion leaders in the Welsh AssemblyGovernment, clinicians (includingconsultants, procurement nurses andclinical researchers), clinicalacademics, and industry are able tomeet and discuss important issues thataffect the sector. The ease with whichthis occurred could be down to goodcommunication networks, however it isalso likely to be a result of a devolvedhealth service and a relatively smallnation, which makes high level accessacross interest groups that mucheasier. Whatever the reason, meetingslike this show that Wales is able tocommunicate with little bureaucracyand create working partnershipsharder to achieve in the wider UK. As aresult, Wales has a unique opportunity

international partnerships and inwardinvestment. Like the Welsh Biosciencesector, the event has grownsubstantially since inception: last yearit attracted over 400 delegates withmore than 40 exhibitors.

Next year’s conference is themedaround regenerative medicine; stem-

Eminent speakers from both industryand academia will describe some ofthe recent developments in theseareas, helping to map future trends inthe Bioscience landscape.

Underpinning the success of strongnetworks and collaboration, Wales hasa vibrant manufacturing base; a largenumber of innovative medical devicecompanies; world-renowned academicinstitutions; and academic and clinicalcentres of excellence.

These strengths, combined with theeffects of the sector mapping project,the clinical access initiative and astrong programme of regular events,has made Wales and the sector anexciting and vibrant environment towork in. Confident and self aware ofits own strengths, there is anunderstanding of how things currentlystand, which helps to set goals andtargets for the future.

Bioscience’s successes have beenhighlighted, but the sector is alsohonest about where it needs toimprove. The deep-routed networksand willingness by key players toimplement change and be involvedshow that the sector - and indeedWales - is proactive, not just reactiveto problems. As Wales takesadvantage of its skills andopportunities, there will be a multiplepay-off: enormous potential forimproved healthcare, reduced costs,economic benefits, and increasedinward investment. The unique andsustained identity of Wales as a small,but clever devolved nation, places thecountry in a position to pushBioscience as Wales’s strongestsector.

6

BIC Innovation, Wales’ leading innovation

consultancy, believes in the power of change.

● Strategy & Planning

● Commercialisation of Intellectual Property

● Market & Feasibility Studies

● Concept Development

● NPD

● Manufacturing & Process Development

● Performance Improvement

● Workplace & Skills Innovation

Need an injection of Innovation?

B I C I N N O V A T I O N A N D P E R A C L I E N T S

NEW in 2009Pera Cymru is a partnership between BIC Innovation & Pera, Europe’s leading innovation and performance improvement organisation.

BIC Innovation & Pera CymruPencoed Technology Centre, Bridgend CF35 5HZ

T: 01656 8615361 Llys Onnen, Parc Menai, Bangor LL57 4DF

T: 01248 671101Contact: Huw Watkins 07816 650974 / huw.watkins@bic-innovation.com Rod Howells 07920 563576 / rod.howells@pera.com

www.bic-innovation.com

3 9

Jill TaylorSales Manager

Boots Centre for Innovation

Gail Easthaugh James Ellis

Blizzard Protection Systems

Head OfficeUnit 2Coed y Parc Industrial EstateBethesdaGwynedd LL57 4YY UKTel: +44 (0) 1248 600666

Blizzard Protection Systems manufacture the thermally resistantmaterial Reflexcell™. Recent winner of the Queen’s Award for Enterprise: Innovation,Reflexcell™ is a triple layered metallised polymer foil whichexpands to form insulating air pockets as well reflecting heat. It islightweight and has excellent insulating properties. BlizzardProtection Systems use the material to manufacture their BlizzardSurvival range of products including jackets, blankets and sleepingbags and also to manufacture the self heating product BlizzardHeat. Blizzard products are used in the treatment of hypothermia,shock, injury and other extreme outdoor situations.Blizzard distribute in over 30 different countries worldwide, to 7 keymarket sectors; Military – medical and infantry; Medical – civilian;Emergency Services – Ambulance, Police, Fire service etc; Search &Rescue; Emergency Preparedness; Outdoor retail; Disaster Reliefand Corporate HealthcareOur trip to Medica will help us to reinforce our position with existingcustomers and we also hope to attract new customers and toexpand our worldwide distributor network.

Institute of Life Science,University of Swansea, Swansea, SA2 8PP Wales, UK Tel: + 44 (0) 1792 513 722Email: info@bootsinnovation.co.ukWeb: www.bootsinnovation.com

The Boots Centre for Innovation seeks out innovative health andbeauty products at any stage - from concept to shelf-ready - forAlliance Boots pharmacy-led stores worldwide. It offersentrepreneurs an array of support services essential to thecommercialisation of their ideas. Embracing the principles of OpenInnovation, the Centre compliments the established productdevelopment resources of Alliance Boots. Sitting at the centre of a dynamic knowledge network, the BootsCentre for Innovation also identifies and evaluates key trends andemerging opportunities in the health and beauty markets and helpsbring together expertise from industry, academia and theprofessions to define the future direction of those markets.Objectives at Medica:Seek out innovative consumer healthcare products and serviceswhich are suitable for Boots stores in the UK and throughout theglobal Boots distribution network. Identify opportunities that could meet our customers’ unmethealthcare needs.

W A L E S P A V I L I O N D I R E C T O R Y

International Business Wales (IBW) is the Welsh Assembly Government’s international trade and investment arm. It forms partof the Department for the Economy and Transport, and acts as thedriving force in establishing alliances between companies in Walesand their counterparts overseas, whilst actively seeking out inwardinvestment opportunities for client companies looking to Europe andthe UK as a preferred international business location.

Helen is responsible for developing trade for Welsh companies withinEurope. In doing so, she manages a network of businessconsultants based throughout the Region and leads a number ofbusiness delegations from Wales to key European markets and tradeshows.

Welsh Assembly Government Department for the Economy and Transport, Plas Glyndwr, Kingsway Cardiff CF10 3AH Tel: +44 29 2082 8788 Fax: +44 2044 2696 Email: helen.marie.griffiths@wales.gsi.gov.uk Web: www.ibwales.com

Helen GriffithsRegional Manager - Europe

International Business Wales

Sony UK Technology CentrePencoed Technology Park • Pencoed

Mid Glamorgan • CF35 5HZTel 00 44 1656 860666 • Fax 00 44 1656 863906

Uktec.enquires@eu.sony.com • www.sonyuktec.co.uk

35 years, world class engineering experience

World leading manufacturing facilities

10,000 Sq meters – factory space

3 million shots per day auto mount facility

First class worldwide distribution network

9,000 Sq meters –Warehousing space

Extensive Product approval and testing facilities

6,000 Sq meters – Office space

On-site customer service call centre

Service repair solutions

The Complete Business solution

Contract electronicsmanufacturing excellenceContract electronicsmanufacturing excellence

W A L E S P A V I L I O N D I R E C T O R Y

CellNass Europe

Cardiff Medicentre

Paul Webber,Director

W A L E S m e d i c a s p e c i a l

Heath ParkCardiff CF14 4UJSouth WalesUnited Kingdom Tel: (029) 2075 7744Fax: (029) 2075 0239Email: enquiries@cardiffmedicentre.co.ukWeb: www.cardiffmedicentre.co.uk

The Cardiff Medicentre is Cardiff’s premier home for medicalinnovation businesses in Cardiff. The Centre was the first of its kind inthe United Kingdom and offers an attractive environment for new anddeveloping medical and pharmaceutical based enterprises.The Centre is located on the University Hospital of Wales campuswhich extends across 53 acres and provides a working base for over4,000 people. In addition, the campus is also home to Cardiff UniversityMedical School.Becoming a tenant at the Medicentre will enable your company tobring the innovative and practical application of medical or bioscienceresearch efficiently to the marketplace.The Cardiff Medicentre is therefore the ideal place to develop yourmedical, bioscience or life sciences technology based business,offering:Encouragement for business growth; competitive rents and flexibleterms; a prestigious location; close links with Cardiff University & thelocal NHS Trust; access to focused business support packages; and a strong cluster of medical technology businesses

80 Mochdre Enterprise ParkNewtownPowys SY16 4LETel: +44 (0)1686 611333Fax: +44 (0) 1686 622946Web: www.cellnass.com

CellNass is the innovative archive management service arm ofCellPath Ltd. For the past 40 years Cellpath has been supplyingconsumables for human tissue sampling to Histology and Cytologydepartments at hospitals and laboratories (see www.cellpath.co.uk);from this initial core activity the company has branched out intomaterial archiving, a logical development into the field of services.Cellnass offers the first dedicated Human Tissue Association (HTA)licensed offsite storage facility for archiving pathology samples in theUK, which is used by well-known private and public hospitals,pathology laboratories and universities. It has a strong team ofprofessionals bringing together extensive expertise in Pathology andlogistics, and has the resources and ability to transport and archivelarge volumes of material safely and without inconvenience to hospitalstaff. Since inception there has been a rapid increase in the number ofestablishments using the facility and there are current plans to expandavailable storage.

10 11

Cellpath

Philip Webber,Managing Director

Brian Reid,Export Sales Manager

80 Mochdre Enterprise ParkNewtown, Powys SY16 4LETel: 01686 611333Fax: 01686 622946Email: Philip@cellpath.co.ukWeb: www.cellpath.co.uk

CellPath feel that there is a lot of potential for expansion in Europeanmarkets, and has appointed a Business Development Manager to seekout new opportunities, primarily in the near European countries where adetailed analysis of the markets has already been undertaken in-house.There is a real belief within CellPath that there is ‘untapped’ potential,particularly in the eastern European countries: the company would liketo use Medica to help find a business partner in Europe.Cellpath has established itself as a dynamic innovative company, andhas anenviable reputation over 25 years for reliability and customerservice in its role as market leading supplier of cellular pathologyconsumables. In addition to supplying a comprehensive range ofpathology consumables, Cellpath continues to be at the fore-front of thedesign and development of new products. Cellpath has the resources tooffer contract manufacturing, processing and packaging, as well aswarehouse and distribution for customers looking to outsource theselabour-intensive operations.Objectives at Medica:Increase export market by meeting potential and existing suppliers,distributors and customers

Chromogenex Technologies

Units 1&2 Heol RhosynDafen ParkLlanelli SA14 8QGTel: 01554 755444Fax: 01554 755444kwilliams@chromogenex.comwww.chromogenex.com

Chromogenex design, manufacture and service lasers and intense lightsystems for the health and beauty market. Key products are:ilipo - a body shaping fat reducing device without the need for pain,needles or downtime. Chromolite/Phaser – intense pulse light (ipl) for hair removal, skinrejuvenation and pigmentation. Regenlite – a pulse dye laser for vascular, acne and skin pigmentation. The company also sells consumables, service contracts and otherancillary goods. The company has established direct sales operations in the UK, Frenchand Canadian markets and makes further export sales via acomprehensive network of distributors.

DTR Medical

Andrew Davidson, Managing Director

17 Clarion CourtEnterprise ParkSwansea SA6 8RFTel: +44 1792 797910Fax: +44 1792 797955Email: adavidson@dtrmedical.comWeb: www.dtrmedical.com

DTR Medical provides medical professionals with high quality single-usesterile disposables that deliver patient and clinical value combined withexceptional levels of service. The company has operated for four years,during which time it won over 400 UK & International customers andhas expanded the product range dramatically to meet new marketdemands.The range includes many new sterile single-use surgical instrumentsfor specialities including ENT, neurosurgery, vascular and generalsurgery, and gynaecological procedures. In addition, the companysupplies a range of products for sterile services including sterile pre-cut silicone tubing. Objectives at Medica:Recruit new international distributors to sell our new product rangeworldwide; meet existing distributors and suppliers; and look for newproducts

E2L Products

Lyndon Owen, Managing Director

19 White Swan CourtMonmouthMonmouthshireNP25 3NYTel: +44 [0]1600 714856Email: Lyndon@E2L.uk.comwebs: www.E2L.uk.comwww.megabee.co.ukwww.FAB.uk.com

Services - E2L is a design consultancy specialising in medical devices.Established for over 10 years and recognised as ‘Ambassadors forInnovation’ they offer a complete design package taking products frominitial concept through to manufacture. Clients range from individualswith the ‘big idea’ through to multinationals and public sector bodiessuch as the National Health Service. Joint collaborative ventures orcontract design work is undertaken, as well as developing their ownproducts.Products – Two products are going to Medica: ‘MegaBee‘’ (www.megabee.net) a frequent-use communicator forpeople who cannot speak or write legibly, for MND, MS, locked-insyndrome, and similar disabilities. ‘FAB‘’ Frenchay Alphabet Board(www.FAB.uk.com), a low technology, anti-microbial, finger pointingchart for non-vocal users who have tremors. These are for a similarclient group but include Parkinsons’ Disease sufferers.Objectives at Medica: Medica is an opportunity to identify newdistributors, collaborative design clients, and to introduce out latestinnovations.

Jeremy Jones

Peter McGuinness, Managing Director

Kevin Williams, Sales Director

W A L E S P A V I L I O N D I R E C T O R Y

W A L E S m e d i c a s p e c i a l12 13

Firefly Medical

Ian Mortimer, General Manager

Unit B,Cwm Cynon Business Park,Mountain Ash,CF45 4ER.Tel: 01443 475539Fax: 01443 473379.www.fireflymedical.co.uk

Firefly Medical Ltd was established to develop leading medical productsfor the NHS and primary care fields. Augmented with selective sales ofleading equipment, consumables and pharmaceuticals. We have aexperienced external sales team with strengths in occupational health,primary care and sexual health. We will shortly develop our websitefurther to actively promote a broad product range.We are ISO13485:2003 accredited and have a pharmaceutical wholesaledealers license.We design and manufacture medical products. We have recently launchedour own design and manufactured Sterile Vaginal Speculum which is theleading product in the market. Having recently been accepted on theframework agreement for the NHS, we are now looking to exportthroughout Europe and Middle East.Objectives at Medica:We are now looking for distribution partners across Europe for thePuraspecTM; we have identified a number of distributors and are looking formore. We are also interested in potential partner distribution of ownbranded products within the U.K.

GX Group

Claire BanksBusiness Development Manager

The MayfieldUsk, Monmouthshire, WalesNP15 1SY United KingdomTel: +44 1291 673437Fax: +44 1291 673438Email: claire@gxl.co.ukWeb: www.gxl.co.uk

GX is a leading independent design consultancy. We have a proven tractrecord in high quality design, development and manufacture ofinstruments, machines and products for the medical sector.Recent clients include: Bayer Diagnostics, Gyrus Medical, Rhytec, CLP,Pall, Medical Support Systems, Morecare and British Gas.GX’s committed and experienced workforce combine technical excellenceand design innovation to meet clients’ needs. Key areas of expertise, allavailable in-house, include:Industrial design, Mechanical engineering, Electronic design, Rapidprototyping, Optronics design, Software design, CAD animationsGX Systems is a leading independent systems integrator. We have a proventrack record in the high quality provision of automation and controlsystems. We have the skills to provide a complete Turnkey Solutionincluding Hardware, Control and project management to bring your projectin on time. Recent clients include: British Airways, Celsa UK, BAAE, Serco, Falkirk CCand Cardiff University.Key areas of expertise, all available in-house, include: Vehicle locationsystems, Mobile workflow systems, Asset Management, PLC’s systems,SCADA systems, MES Systems, Instrument and Control panel build, Aftersales support

HSBC Bank Plc

Edward White, Regional International CommercialManager

97 Bute StreetCardiffCF10 5NAedward.white@hsbc.comwww.hsbc.co.uk

HSBC Holdings plc serves over 130 million customers worldwide through9,500 offices in 86 countries and territories in Europe, the Asia-Pacificregion, the Americas, the Middle East and Africa. With assets of someUS$2,527 billion at 31 December 2008, HSBC is one of the world’s largestbanking and financial services organisations. HSBC is marketed worldwideas ‘The world’s local bank’.HSBC has over 8,000 Relationship Managers operating globally, with over1,600 in the UK dedicated to helping businesses maximize their potential.HSBC has over 200 international product specialists in the UK helpingSMEs with importing and exporting. HSBC has over 55 Multi-lingualInternational Banking Centres worldwide which specialise in openingaccounts in overseas markets to help businesses make the transition.HSBC are attending Medica 2009 to further it’s links with InternationalBusiness Wales in Germany and mainland Europe, and build relationshipswith businesses from Wales benefiting from global opportunities.

Magstim Company

Andrew Thomas, Marketing ManagerJohn Scandone, International Sales Manager

Spring GardensWhitlandCarmarthenshire SA34 0HRTel: +44 (0) 1994 240798Fax: +44 (0) 1994 240061Email: andrew.thomas@magstim.com

Magstim provides the means for neuroscientists to work with the humanbrain in awake subjects by manufacturing and supplying state-of-the-artclinical and research instruments. Magstim and Neurosign products coverthe fields of Neurology, Neurophysiology, Psychiatry, CognitiveNeuroscience as well as ENT, Orthopaedic and Neuro-surgery.Magstim maintains a strong commitment to R&D and productimprovement. Collaborating with researchers in British and Europeanmajor centres of expertise (as well as those in North America and Japan)ensures that Magstim remains informed about clinical and medicaladvances, enabling the company to develop products at the forefront oftechnology.Products are sold directly to hospitals and clinics in the UK and Ireland andexports account for much of the Magstim business. Our principal marketsare in Germany, France, Benelux, Japan, the Far East and the USA.Magstim enjoys a close and effective relationship with its specialistdistributors and provides significant training and after sales service.

Home Telehealth

Saint Line House Mount Stuart Square Cardiff CF10 5LR Tel: 029 2044 4795 Fax: 029 2044 4778 E-mail: peterbw@hometelehealthltd.co.ukWeb: www.hometelehealthltd.co.uk

Peter Brooke-Wavell

HTL is a provider of Telehealth Managed Services dedicated to bringinginnovation to Health, Social Care Providers, Industry and Consumers.HTL’s objective is to leverage its experience of working within both thepublic and private Healthcare markets on the delivery of new value-addedservices and solutions that deliver new applications generating improvedclinical, operational and financial outcomes for our clients.The HTL portfolio of services, products and solutions extends across manysegments of Health and Social Care including Health and Wellbeing,Chronic Disease Management, Telehealth, Telemedicine, Telecare, AssistiveTechnologies, eHealth grouped into three segments: technology solutions,managed services, programme implementation.

W A L E S m e d i c a s p e c i a l14

W A L E S P A V I L I O N D I R E C T O R Y

15

Gwyn Tudor, Forum Manager

5-7 Schooner WayAtlantic WharfCardiff CF10 4DZTel/Fax: 029 2047 3456Email:debbie.laubach@mediwales.comgwyn.tudor@mediwales.comWeb: www.mediwales.com

MediWales has been active for over seventeen years and is the representativebody for the health technology sector in Wales. With over 120 subscribedmembers, we are in regular communication with over 1,500 contacts.Supported by the Welsh Assembly Government, MediWales is owned by itsmembers and led by directors drawn from senior industrialists and academicsin Wales. MediWales generates a unique environment for networking, collaboration andcommunication between industry, higher education and health servicemembers. This is delivered through an active schedule of seminar events andpublications, supported by the MediWales website and maintained via constantcommunication with members and stakeholders. From this pivotal role,MediWales is able to represent both its members and the wider sector togovernmental and international partners. Objectives at Medica:Debbie will be available on the Welsh stand to find out more about yourbusiness and promote the interest of our members and the sector.

Stuart Reid, Business Development Manager

Unit 20, Abenbury WayWrexham Industrial EstateWrexham LL13 9UZTel: 01987 661 999Fax@ 01987 661 705Web: www.nightingalebeds.co.ukEmail:info@nightingalebeds.co.uk

Nightingale Care Beds Ltd is based in Wrexham, North Wales and is amanufacturer and supplier, for sale and hire, of a range of bariatric productsdesigned to suit the larger patient. Nightingale supplies into the NHS(primary, secondary and acute), community, private health care suppliers aswell as private individuals and is an approved supplier on the NHS supplychain framework agreement for beds and pressure area care products.Nightingale services are based around its core product the ProAxisplusbariatric bed with in built pressure area care system. The remainder of ourproducts are designed to support the needs of the patient and their carers.We base our designs on ergonomic data supported by consultation withexperts in manual handling, infection control and tissue viability plus patientfeedback.Objectives at Medica:At Medica, Nightingale is seeking equipments that may compliment ourcurrent product range and to identify businesses where we may be able todevelop mutually beneficial business links.

Dr Mark Fisher, CEO

Aberystwyth UniversityCommercialisation &Consultancy ServicesVisualisation CentrePenglaisAberystwyth SY23 3BFT: 020 7812 7366M: 07967 086592E: mfisher@exomedica.comWeb: www.oncomorph.com

Oncomorph Analysis, a spin out company from Aberystwyth University, wasfounded in 2008 to develop the use of existing MRI data with new imageanalysis software to improve the diagnosis and staging of prostate cancer. The company is developing a suite of software tools, including annotationand segmentation functions, for both external and internal tissueidentification and a 3D registration tool, to yield tissue volumetric data. Thecore technology that enables Oncomorph Analysis to interrogate digitalimages is a shape/texture-based segmentation tool that can differentiatebetween the patterns of a tissue through the analysis of a small number ofthe total pixels that make up the larger image area. This reduces theamount of data that needs to be ‘crunched’ and speeds up the wholeprocess of analysis. Objectives at Medica:The aim of going to Medica is to establish links with existing imagetechnology businesses to broker joint venture opportunities to accelerate theroute to market.

Jarred Evans, Commercial Director

Western AvenueCardiff CF5 2YBT: 02920 416725F: 02920 416973E: jwevans@pdronline.co.ukW: www.pdronline.co.uk

PDR is one of Europe’s leading product development consultancies andresearch centre’s. It offers services of innovation, design andengineering development, prototyping, low volume manufacture andoffshore manufacturing support. With over 15 years of experience PDRhas developed a reputation for excellence in medical devicedevelopment. With a collection of over 10 international design awards inthe last three years alone PDR has a proven and reliable record ofdelivery.We consistently create successful products, and solutions for companiesand organizations from around the world and across many markets. Ourclient base encompasses new start-up ventures to large multinationalsto which we provide the unique combination of leading edge researchwith world class creativity, experience and application.PDR’s core efforts focus on the rapid design development of newmedical products to the market place. Combining the user-insight withcreative skill and engineering expertise to produce reliable, highlysuccessful and market changing solutions.Objectives at Medica:To strengthen new client relationships and opportunities; to showcaseour success in new product development.

Chen Jun, Manager of International Trade -Chongqing Tianhai Medical EquipmentCompany LtdLong Haiying, Managing Assistant of InternationalTrade - Chongqing Tianhai MedicalEquipment Company Ltd

Regus Cardiff CityHaywood House NorthDumfries PlaceCardiff,CF10 3GATel: +44-(0)29-20647384Fax: +44-(0)29-20646101Mobile: 07517690898E-mail: isabella.li@c-thme.comHead office website: www.c-thme.com

Tianhai UK Ltd, located in Cardiff, is an European subsidiary ofChongQing TianHai Medical Equipment Co., Ltd, which is a Hi-techcompany established in 1995 specialized in R&D , manufacturing, salesand marketing, and after sales service of medical equipments used inHospitals, Clinical Laboratories, Research Institutes. Three Main Technology Lines:1)Clinical Inspection Analysis & Diagnostic Technology—Urinalysis, Blood Analysis, Medical Image Analysis, TraditionalChinese Medical Diagnosis2)Blood Purification Technology—Hemodialysis Machine, Multifunctional Pump3)LED-based Medical Illumination Technology—LED Medical Illumination ProductsTianhai UK Ltd is at its early stage aiming:—To strengthen the cooperation with ENFIS. To promote medicalequipment in UK market. To meet with potential distribution partners.To meet with possible new clients and associates. To seek morepartners in the sustainable energy.

Lee Watkins, Healthcare Sales Manager

Eastgate Business ParkWentlog AvenueCardiff CF3 2EYTel: +44 (0) 845 330 4236Fax: +44(0) 845 330 4231Email: admin@ultrawave.co.ukWeb: www.ultrawave.co.uk

Ultrawave have been manufacturing precision ultrasonic cleaningequipment for over 15 years for a wide range of industries and applications.In this time, Ultrawave have developed a range of cleaners for healthcareand medical environments including hospitals, sterile service departmentsand primary care facilities as well as by medical device manufacturers andpharmaceutical companies.The Hygea™ range of ultrasonic cleaning baths address modern standardsof decontamination and incorporate a locking lid and integral printer forcycle traceability and validation. The Q-Series benchtop ultrasonic bathsdeliver improved cleaning through Frequency Leap technology and allowdigital cycle traceability through an SD card port. In addition, Ultrawave canoffer a range of tailored options, including hollow lumen instrumentcleaners and ultrasonic tanks which can be inserted into wet benches.Ultrawave’s precision ultrasonic cleaning equipment is also used in themedical device and pharmaceutical manufacturing industry.

Tianhai UK

Ultrawave

PDR

Oncomorph Analysis

Nightingale Care Beds

MediWales

Debbie Laubach, Project Manager

Chris Czyrko, Sales andMarketingManager

W A L E S m e d i c a s p e c i a l16 17

Paul Mayberry, Managing Director

175-177 High StreetBlackwoodGwent NP12 1AAUKTel: 01495 228040Mobile: 07790906168

Unit 10 Distribution Ltd is a collector of UK ethical drugs. The companytakes advantage of the strict stock quotas imposed by manufacutures,the price descrepancies of drugs between European counties and theexchange rate. Drugs are sourced from a group of independantly ownedretail pharmacies in South Wales. They are consolidated centrally anddistributed to customers using state of the art robotic technology. Unit 10 Distribution currently exports over £20 million pounds annually ofbranded pharmaceuticals to Europe (mostly to Germany andScandinavia), through UK based third parties. Unit 10 Distribution would now like to export directly to Europe, and iscurrently looking for strategic partners in Germany in order to do this.

Welsh Wound Network

Dale Harper (MSc)University of Wales Institute Cardiff (UWIC)

200 Western Avenue Cardiff CF5 2YBT: +44 (0)2920 417 052E: uwicresearch@daleharper.co.uk W: http://www.uwic.ac.uk/research/

The University of Wales Institute, Cardiff (UWIC) engages in research thatis at the interface of new knowledge creation and its application. Theresearch, therefore, has direct application in business, industry, theprofessions and the community at large.The University of Wales Institute, Cardiff (UWIC) has a long track recordin applied research supported by a strong base of expertise andadvanced scholarship.For the prospective student, this translates to an exciting and variedprogramme of postgraduate study ranging from art and design,education and health sciences to critical management, sport andtourism.For business partners and collaborators, we offer a portfolio of servicesthat includes research and development, consultancy, and training tohelp enhance performance, improve competitiveness and develop theskills base.Dale Harper will be representing UWIC R&D and will be happy to assistyou, whether your needs are for basic advice, research, consultancy,education or training.

Wentwood Medical

Wentwood Medical Ltd provides sales and marketing expertise to thebiotechnology and pharmaceutical sectors in the UK and Europe. Ourservices include:• Strategic brand planning services, strategic marketing formulation andplan development. Integrated customer plan development, customertargeting strategy development, strategy implementation, operational brandmanagement services and brand enhancement programmes.• Pre-launch activities (market assessment, market shaping), brand supportprogrammes, patient programmes and aligning to NHS customers.• Marketing material production, web site design, customer, key opinionleader management and development. NHS funding expertise, NHS liaison,PCT contact• Communication with policy, formulary, funding & commissioning decisionmakers and Government lobbying. Sales targeting strategies and sales forcere-design• Alliance management - co-promotional activities, start up company Sales,marketing and business development supportObjectives at Medica:To make contact with pharmaceutical/healthcare companies who:Have a product or technology looking for entry to the UK market; are lookingfor distribution/agency agreements for products/services in the UK; areseeking sales/marketing or business development support in the U/Globally;and have a need for sales & marketing support projects

Zoobiotic

Dunraven Business ParkCoychurch RoadBridgendCF31 3BGTel: 0845 2301810Fax: 01656 668047Website: www.zoobiotic.com

ZooBiotic Ltd is based in Bridgend, South Wales and manufactures andmarkets larvae products for the treatment of sloughy and necrotic wounds.All products are produced in accordance with current European 'GoodManufacturing Practice' (GMP) requirements in our state-of-the-art asepticfacility.'Free range' LarvE® and our BioFOAM® Dressings are Zoobiotic Ltd's coreproducts. BioFOAM® dressings consist of larvae that are enclosed in net poucheswhich contain pieces of hydrophilic polyurethane foam. The BioFOAM® Dressings can be left on a wound for up to 5 days. Eachdressing is supplied in a plastic oyster as well as a paper/polythene bagwhich acts as a microbial barrier and is permeable to air.The 'free range' LarvE® are applied directly to the wound and seek out areasof slough or necrotic tissue. They are concealed in a net dressing or similar.'Free range' LarvE® can be left on a wound for up to 3 days. LarvE aresupplied in a sterile container with a lid that is permeable to air and acts asa microbial barrier.

Scott Forde, Managing Director

The ManseTabernacle LaneLlanvachesMonmnouthshire NP26 3BLTel: + 44 (0) 7748 637400E mail: scottforde@wentwoodmedical.com

UWIC Research

Dr Michael Clark, Senior Research Fellow

Would Healing Research Unit (WHRU)School of MedicineCardiff UniversityHeath ParkCardiff CF14 4XNTel: 029 2074 2323Email: clarkm@cardiff.ac.uk

The Welsh Wound Network is a new collaborative organisation dedicatedto improving the clinical care of people with wounds in Wales. Thenetwork brings together the wealth of academic, clinical and commercialexpertise in wound healing in Wales to facilitate the development of newpractices and innovations by undertaking high quality collaborativeresearch, audit and other enquiries.There are several well known and internationally respected research andclinical groups located in Wales including the Wound Healing ResearchUnit, the Surgical Materials Testing Laboratory, the All-Wales TissueViability Nurse Forum among several others. In this new venture all ofthese well established groups have come together to explore areaswhere collaboration would lead to enhancements in research, practiceand commercial innovation. This ongoing communication is supportedby a roster of conferences and other networking events throughout theyear.

Unit 10Distribution Ltd

Unit 10 Distribution

Gill Davies, Gareth Kempson,Suzanne Morgan,Alan Morgan,

Physicool, a unique stretchy reusablebandage with an interesting story,has been launched by the BootsCentre for Innovation. Available onsale through the Boots website,this is yet another product tobe launched by the Centre, anot-for-profit organisationthat seeks out innovativehealth and beauty productsat any stage – from conceptto shelf ready – for AllianceBoots pharmacy-led stores.

When Physicool is appliedto a physical strain or injurythe temperature of theaffected area dropssignificantly, about 10C-15C. It can be usedstraight out of the pack,without prior need tofreeze or introduce ice aswith other solutions. Thecooling and compressionprovide instant treatmentfor inflammation andbruising of muscles, tendonsand ligaments; by rapidlyreducing swelling and pain,the bandage helps to speed upthe healing process. The coolingeffect lasts approximately 2-3hours; even after the bandagehas been removed it works bydrawing heat out through rapidevaporation, whereas otherproducts work by conducting cold in.The Physicool range comprises fourproducts: three bandage sizes whichaddress different body areas, and arecharge solution allowing further usefrom exhausted bandages - which canbe washed as necessary.

The Boots Centre for Innovation teamspotted the unique product at anexhibition - the NHS HealthcareInnovation Expo - earlier this summer

and identified them as a strongpotential addition to the Boots first aidrange. Whilst the process of adoptionwas underway, the Director ofPhysicool, Kay Russell, secretly filmedher pitch to the notoriously shrewdpanel of investors on the BBC

Dragons’ Den. Due to confidentiality,Kay couldn’t disclose to the Centrethat she’d won significant investmentuntil completing her episode. After

discussions on how they couldcapitalise on the media

attention, the Centre wereable to bring forward thelaunch on www.boots.com tocoincide with the TV show inAugust 2009.

BBC’s Dragons’ Den arecurrently discussing with Kayabout featuring Physicool ina follow-up programme thattracks the dragon’sinvestment and involvementin the company. Boots andthe Boots Centre forInnovation may well befeatured in this opportunity.Aside from the Dragons’ Den,Physicool is also supported byfamous cricket player AndrewFlintoff. Andrew’s been usingthe product for pain relief andto accelerate recovery frompersistent injury problems forsome time. Physicool is intalks with Andrew’s agent forfuture endorsement, makingadditional media attention verylikely.

Boots Centre for Innovation

18

S H O W C A S E S

19

Boots Centre for InnovationInstitute of Life Science,University of Swansea, Swansea, SA2 8PP Wales, UK Tel: + 44 (0) 1792 513 722Email: info@bootsinnovation.co.ukWeb: www.bootsinnovation.com

W A L E S m e d i c a s p e c i a l20

S H O W C A S E S

21

The Dynamic Gastric Model (DGM) isa state-of-the-art simulation ofhuman gastric processing. A truly‘dynamic’ in vitro system, itreplicates the biological functions ofthe human stomach. The GX Designteam took an existing prototype andthrough collaboration with theirclient transformed the artificialstomach into an exciting exploratorytool for the medical industry.

The brief given to GX DesignEngineers by their client PBL beganat the client’s Norwich based “ModelGut” laboratory at the Institute ofFood Research (IFR). Here, the in-useprototype was introduced to functionalupgrades, which resulted in theimproved - and now commerciallyattractive - second-generation DGM.

The DGM provides predictivesimulations of the key conditions andprocesses which take place in thehuman stomach. Real foods andmeals are processed in real time,providing digested samples for furtheranalysis with full data readout viacomplex computer software control.Previous to GX Design Engineer’sinput, the DGM consisted of severalindependent systems in order tofacilitate full operability. GX DesignEngineers optimised the design bycombining multiple systems andintroducing new design elements. Theupgrades enabled their client to takethe newly branded DGM to market,primarily aiming at the food andpharmaceutical industries.

The process begins in the newlydesigned Charge Station. Acid andenzyme fluids are stored fordispensing in a stable, temperaturecontrolled environment. Here, fluidscan be quickly and easily refilled

before being accurately pumped tothe Processing Station via a ‘pulsefree’ pumping system.

The Processing Station is based upona three-stage modular design whichreplicates the physical mixing of foodand gastric secretions that occur inthe human stomach. The initial stagetakes place in a flexible funnel intowhich food is entered and mixed withacids and enzymes. As a result,specialist materials and finishes wereselected to chemically resist thecorrosive nature of stomach acid. Thisproved technically challenging whenincorporating transparency into thedesign in order to facilitate viewing offood materials being processed.

Food is then fed into the second stageof the process, which simulates thedigestive activities of the lower part ofthe human stomach (antrum).Located in the central column of theProcessing Station, food is subject tosimulated physiological shear from acompletely redesigned valve system.This novel design improvesfunctionality through increased flowchannel diameter and reduced deadvolumes, resulting in increasedreliability and achieves closercharacteristics to the human stomachit is modelled upon.

In the third stage food material thenleaves the Model via a new valvedesigned to give minimal sample loss,into a sample container nowaccessible without processinterruption. This facilitates discretesampling of the digesta output.Simulated digesta can then beanalysed and taken on to anadditional stage simulating duodenaldigestion.

GX Design Engineers haveimplemented new ideas anddevelopments spawned from adynamic working relationship withtheir client. “GX Design Engineershave taken a basic prototype andskilfully woven new features andimprovements into the design in arelatively short timescale. We arereally excited to see the new DGM inall its working glory”, said Dr MartinStocks, Business DevelopmentManager of PBL and the Model Gutunit.

GX SystemsDTR Medical - the rapidly growingspecialist in sterile single-usesurgical instruments - is seeing asignificant rise in enquiries frommany parts of Europe, Middle Eastand beyond, underlining the growingneed for high quality disposableequipment.

DTR Medical believe there are severalfactors influencing the increase insales for sterile single-useequipment. Firstly, steriledisposables reduce therisk of cross-

contamination.Complications like

surgical site infections andextended hospital stays areminimised, which lower costs andreduce potential litigation. Secondly,disposables rule out reprocessing –the need to clean reusableinstruments. Reprocessing is adifficult and timely process, oftenleading to delayed patient throughputand raised costs from high manualhandling rates.

Another positive with single-usedisposables is that they don’t needconstant validation and repair, whichis expensive and can disrupt theatreprocedures if reworking is delayed.Lastly, with reusable equipment thereis the issue of replacement capital:busy units demand multiple sets tocope with high patient numbers. Thisis even more expensive where re-processing is done away from theclinical location, making funding oftenmuch more than anticipated.

These cumulative cost-saving andpatient benefits are being noticed farand wide. During a recentinternational ENT symposium inLondon - the 27th Politzer Society -leading surgeons from across Europeexpressed interest in using DTRMedical’s single-use instruments intheir own clinical practice. Somedelegates were so committedto these

potentialbenefits, that they placed

orders during the meeting.

Single-use surgical instruments arenot designed to replace all re-usableitems, but are most effective whenused selectively to resolve acombination of the above factors.Managers of sterilisation services areacutely aware of these issues andwelcome the support disposableproducts bring them. For instance,validating the sterility of long lengthsof tubing is often problematic: DTRMedical eradicates this problem bysupplying its range of pre-cut lengthsof sterile silicone tubing, which arenow being sold in markets as farafield as New Zealand.

To help hospital efficiency, single-usedisposable instruments must be of aconsistent high quality, but also bereadily available at all times. DTRMedical takes particular care toensure every instrument meetsspecification and it uses a wide rangeof manufacturing processes to ensurethese can be reproduced repeatedly.

In order to keep up with the need ofits users, the company is alwaysimproving and re-evaluating itssystems. DTR Medical recentlychanged its method of manufacturinga series of medical instruments – theFrazier Suction Handle Range – inorder to allow for greater flexibilityand efficiency. The range, used acrossmost surgical specialities, nowincludes two and four tipfenestrations. This modifiedmanufacturing process has enabledthe potential for more lines ofproducts. A similar approach hasbeen used to produce a range ofsterile single-use Tibbs ArterialCannula, which are used in manyvascular procedures.

Growing international demand meansDTR Medical must plan ahead, andthis is creating new partnerships withWelsh Universities to deliver majornew lines, including importantdevelopments in gynaecologicalsurgery.

DTR

DTRSwansea SA6 8RFTel: +44 1792 797910Fax: +44 1792 797955Email: adavidson@dtrmedical.comWeb: www.dtrmedical.com

GX SystemsThe MayfieldUsk, Monmouthshire, WalesNP15 1SY United KingdomTel: +44 1291 673437Fax: +44 1291 673438Email: claire@gxl.co.ukWeb: www.gxl.co.uk

W A L E S m e d i c a s p e c i a l22

PDR – The National Centre forProduct Design and DevelopmentResearch – was employed by ProMedical Innovation, A Cardiff basedventure, to produce ‘proof ofconcept’ prototypes as the companyembark upon the commercialisationof Safeceps™

PDR have produced the latest versionof demonstration prototypes to helpsecure latter-stage investment andtake this revolutionary medicalproduct to market.

The Safeceps™ are a modern-dayplastic adaptation of the traditionalobstetric forceps. The productencompasses a number of patentedtechnologies which allow for thecategorical measurement of tractionand compressive force exerted uponthe fetal head during instrumentaldelivery. The Safeceps™ are used inconjunction with a monitoringsoftware system (called theSafeGuard™) which visualises andrecords the measurement data inreal-time, changing a subjectiveoperation to a systematic andevidenced based procedure.

Creation of a proof-of-concept unitrequired the application of state-of-the-art prototyping and designtechnology. Challenges includedencapsulating an electronicallyembedded three-dimensional metalcomponent within a thinbiocompatible elastomeric. A numberof units had to be produced in days

and to a very high standard. Usingtechnologies such as selective lasermelting and vacuum castingalongside traditional tool-makingskills, a number of successful unitswere produced and the necessaryinvestment was secured.

S H O W C A S E S

The National Centre for Product Designand Development Research (PDR)

BioWales 2010 sessions will feature:

• Translational Research – what is it?

• Stem Cells – industrialisation for drug development and therapy.

• Point of care diagnostics.

• Cancer Genetics.

• Futurewatch – an introduction to what’s hot and new inbioscience today.

Biopartnering Event at BioWales 2010

Run by Enterprise Europe Network Wales and linked to the EUEnterprise Europe Network, the Biopartnering event provides acatalogue of high quality technology profiles and a base allowingone to one meetings to discuss partnering opportunities.

BioWales 2010 introduces the Welsh bioscience sector toan international, commercial, academic and NHS audience.

BioWales features :

• Presentations from innovative companies and academia

• Face to face partnering meetings

• Spotlight on bioscience exhibiting companies

• Workshops

• 2 days of networking opportunities

Speakers for stem cell session include:

• Stephen Minger, GE Healthcare

• Nobel Prize winner, Professor Sir Martin Evans

• Anthony H Davies, Geron Corporation

To make the most of BioWales 2010 register NOW at – www.biowalesevent.com

BioWales 2010Wales’ largest bioscience conference, exhibition and biopartnering event.

17th and 18th March 2010The Vale Hotel, Golf & Spa Resort, Hensol near Cardiff, UK*

*Just 2 hours from London, 30 minutes from Cardiff International Airport with ample free parking.

Medica Biowales Ad NEW.indd 1 26/10/2009 09:36

PDRWestern AvenueCardiff CF5 2YBT: 02920 416725F: 02920 416973E: dharper@pdronline.co.ukW: www.pdronline.co.uk